Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,515,602
+$5,017,058 QoQ
Shares Held
15,437
+5.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#919
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $68,623,451 across 12 Drug Manufacturers - General names. LLY ranks #1 (27.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
15,437 | $18,515,602 | |
| 2 | JNJ |
Johnson & Johnson
|
69,174 | $17,568,120 | |
| 3 | ABBV |
AbbVie Inc.
|
43,329 | $10,903,309 | |
| 4 | MRK |
Merck & Co., Inc.
|
61,354 | $7,883,989 | |
| 5 | AMGN |
Amgen Inc
|
14,486 | $5,245,670 | |
| 6 | PFE |
Pfizer Inc
|
154,501 | $3,720,384 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,027 | $1,787,775 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
10,109 | $1,277,171 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,515,602 | 15,437 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $13,498,544 | 14,676 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $15,977,269 | 14,867 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,058,159 | 14,493 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,712,943 | 12,460 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,598,726 | 11,622 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,613,716 | 12,453 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $9,618,650 | 10,857 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,995,395 | 11,040 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,616,820 | 13,647 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $5,030,599 | 8,630 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $4,586,553 | 8,539 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,797,800 | 8,098 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,892,970 | 8,424 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,225,038 | 6,082 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $1,712,138 | 5,295 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,738,845 | 5,363 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,528,070 | 5,336 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,436,896 | 5,202 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,198,918 | 5,189 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,933,935 | 8,426 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $977,068 | 5,230 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $518,001 | 3,068 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $426,001 | 2,878 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $487,942 | 2,972 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||